Stop TB Partnership’s Post

PATH's TB REACH Wave 10 project, funded by the Stop TB Partnership, engages with the private sector in Myanmar to integrate tuberculosis (TB) services, increase TB notifications, improve treatment outcomes, and ensure high-quality care aligned with international standards. Focusing on integrating #personcentered #TB services into #PrimaryHealthCare, the project makes it easier for people seeking care to access affordable and diverse services, which aligns with Myanmar’s National Strategic Plan. Engaging private providers, pharmacies, general practitioners, private hospitals, and the National TB Program, the project facilitates linkages between diagnosis and treatment of TB and care for other related diseases.     #WorldTBDay #WeCanEndTB     https://lnkd.in/gyCXZA_3 

The Make in India initiative has been pivotal in revolutionizing healthcare solutions, especially in combating diseases like tuberculosis (TB). Introducing a Make in India device for screening and testing TB patients is a significant step towards addressing the low detection rates prevalent in the country. By leveraging indigenous manufacturing capabilities, this device can offer rapid molecular testing, which is crucial for early and accurate diagnosis of TB. The collaboration between Stop TB Partnership, USAID's iNTP, and the Make in India initiative ensures that cutting-edge technology is made accessible even in peripheral healthcare facilities, reaching communities that need it the most. The deployment of Truenat systems across Nigeria exemplifies the effectiveness of this approach. Bringing molecular testing closer to the grassroots level enhances accessibility and enables timely intervention. With improved diagnosis rates, healthcare providers can initiate appropriate treatment protocols promptly, reducing the spread of TB and saving lives. This Make in India product not only addresses a critical healthcare need but also underscores the potential of indigenous innovation to drive positive change in public health outcomes, not just within India but globally. Molbio Diagnostics Sriram Natarajan EY

Reflecting on the last two decades, the strides made in combating Tuberculosis are nothing short of inspiring. Yet, it's critical to remember that our journey is far from complete. While we've made significant advancements, the road to a truly equitable and sustainable response is still ahead of us. As a Public Health practitioner aimed at serving the population at large on Tuberculosis care and treatment I cannot but wonder how far we still need to go to create more awareness on TB as I have had opportunities to speak to health workers at hospitals and Patients diagnosed with Tuberculosis across Local Government Areas As at this month , Most patients are in denial of having Tuberculosis leading to spending thousand of Naira in seeking other treatment services while avoiding TB drugs for fear of Stigmatization. Some patients are holding on to Faith of what their Spiritual heads have told them that they are healed without wanting/having to take drugs, While others are rooted in MYTHS that has led to denial and seeking traditional herbs and treatment. This made me wonder, if the Center of excellence (Lagos state) with 80% of its population as Literates still battle with this , what of other states with high Illiteracy level? As we recognize World TB Day on March 24. This annual event which commemorates the date in 1882 when Dr. Robert Koch announced his discovery of Mycobacterium tuberculosis, the bacillus that causes tuberculosis (TB). I would share some facts on Tuberculosis causes, symptoms and diagnosis which would help in identifying cases if you have anyone with said symptoms. Ps: Tuberculosis testing and treatment is free across primary , secondary and tertiary health centers in Nigeria. The Damien Foundation Belgium Nigeria is a partner in ensuring that case identification and notification rate is increased to reduce prevalence rate. With staff spread across supported Health facilities in Nigeria , To create more awareness, test and treatment, I would say we have achieved a fair percentage in comparison to the World Health Organization End TB-Strategy which is to reduce TB incidence by 80%, TB deaths by 90%, and to eliminate catastrophic costs for TB-affected households by 2030. Remember that it is a communicable disease and as such prevention and control is important. Pogress is not a guarantee of victory. Our achievements are delicate; without vigilance, we risk reversing gains faster than they were made. #WorldTBday #YeswecanendTB #NCDC

Ending TB Together: Key Learnings from the Media Roundtable on Shorter Regimens I recently attended a media roundtable on shorter regimens for tuberculosis (TB) treatment, co-organized by PLAN Health Advocacy and Development Foundation, Civil Society for the Eradication of Tuberculosis in Nigeria (Oyo State Chapter), and TB People. Here are some key takeaways: * *Shorter Regimens Offer Hope:*Mr. Obatunde Oladapo, Executive Director of PLAN Foundation, emphasized the importance of shorter regimens in improving treatment adherence and completion rates. This reduces the burden on patients and increases the chance of successful treatment. * *Media as Partners in Ending Stigma:* Mr. Oladapo also highlighted the media's crucial role in educating the public and combating the stigma associated with TB. Accurate information is essential in our collective fight against this debilitating disease. * Adams Ademola Temitope, a TB survivor and National Coordinator of TB People in Nigeria, shared her experience of the positive impact shorter regimens have had on treatment ease. She outlined the different durations for various TB treatment types: **Tuberculosis Preventive Therapy (TPT):* 1 month * Drug Resistant Tuberculosis (DRT):* 4 months *Multidrug-resistant TB (MDR-TB):*6 months * **Symptoms and Treatment:** The post listed common TB symptoms (fever, weight loss, night sweats, persistent cough) and emphasized the importance of: * Consistent medication adherence for those infected * Early diagnosis by getting checked at hospitals if symptoms arise * Confidentiality and non-stigmatization by healthcare workers and individuals Together, through education, collaboration, and access to treatment, we can end TB. Let's #EndTB stigma and ensure everyone has access to the care they need. #yeswecanendTB #worldTBday2024 #yestoshorterregimen

#NewsAlert: The The Global Fund Fund to Fight AIDS, Tuberculosis and Malaria and the Stop TB Partnership signed a new collaboration framework with the aim of increasing momentum towards ending TB in low- and middle-income countries by 2030! Highlights of the new four-year agreement: 1. Commit to increase collaboration on a wide spectrum of advocacy, policy, technical & programmatic areas. 2. Support countries to early diagnose and treat all people with TB, including drug-susceptible TB and #DRTB. 3. Continue the work in breaking the gender- and human rights-related barriers that prevent people with TB from accessing the services they need, and to address TB stigma. 4. Boost TB preventive treatment through improved access to quality-assured, affordable medicines and diagnostics, as well as by driving innovation and accelerating new product introduction. 5. Continue to work on strengthening critical elements of the health systems in the affected countries: 📣 Supporting community health workers 📣 Improving access to the latest @WHO - recommended diagnosis  📣 Enhance use of data for decision-making 📣 Strengthening supply chains, and pursuing integrated approaches, including through primary health care, to enable the delivery of critical services to people with all forms of TB.  #EndTB #YesWeCanEndTB Peter Sands Lucica Ditiu

Tuberculosis (TB) remains a significant public health challenge in Nigeria, with the country ranking among the highest TB burden countries globally. The disease not only poses a threat to individuals but also strains healthcare systems and economic development efforts. In response to this pressing issue, both governmental bodies and non-governmental organizations (NGOs) #Tuberculosis(TB)remainsasignificantpublichealthchallengeinNigeria

World Tuberculosis (TB) Day, 24 March 2024, continues with the theme “Yes! We can end TB”. TB is still one of the world’s deadliest diseases and recent years have seen a worrying increase in drug-resistant TB. World TB Day is an opportunity to renew commitment, inspire and take action to end TB. Following the United Nations High-level Meeting on TB in September 2023, WHO/Europe is encouraging: •investment •the uptake of the latest WHO recommendations •adoption of innovations •involvement of civil society organizations. In the WHO European Region our focus continues to be on scaling up active efforts to find TB, ensuring the provision of preventative TB treatment for people at high risk, increasing access to quality-assured rapid diagnosis of TB and achieving full uptake of highly effective, safe and short treatment regimens for TB and drug-resistant TB. The latest treatment regimens are people-centred, making it easier for patients to continue with their lives while undergoing treatment, with no injections and minimal hospitalization •kindly follow @kwimbapharma for more health and drugs info #IfahamuDawa #AfyaNiwewe #DawaNiSumu.

Enhancing Tuberculosis Detection in the DRC WHO calls for “meaningful community engagement” as “critical to improve the reach and sustainability of TB services and accelerate progress towards ending TB by 2030”.   We're proud to share our latest achievements in the Democratic Republic of the Congo (DRC) with our new technical brief on tuberculosis detection.   Key Highlights: Improved Diagnostic Capacity: We've strengthened laboratory networks and ensured the availability of essential diagnostic tools.   Capacity Building: Extensive training for healthcare professionals, enhancing their ability to diagnose and manage TB effectively. 44 dedicated community relays and chief nurses reached over 31,000 community members, providing vital TB information and screening for symptoms.   Community Engagement: Innovative approaches to raise awareness and increase community participation in TB detection and treatment.   These efforts are pivotal in the fight against TB, ensuring timely and accurate diagnosis, which is crucial for effective treatment and control of the disease.   Read the full technical brief to learn more about our comprehensive strategies and impactful results: https://lnkd.in/emZnXcz6   #HealthSystems #Tuberculosis #GlobalHealth #MTaPS #DRC #HealthcareInnovation

Access to health care is crucial to preventing diseases like tuberculosis (TB). In Bangladesh, scientists and nonprofits are joining forces to bring innovative solutions like mobile X-ray machines to communities most likely to have TB. These portable tools help to detect the disease earlier and provide lifesaving care to people who need it most. As researchers and leaders, we need to support efforts like these and advocate for increased access to quality care everywhere. https://lnkd.in/eca4Hq_d 

Tuberculosis (TB) remains a significant public health challenge in Nigeria, with the country ranking among the highest TB burden countries globally. The disease not only poses a threat to individuals but also strains healthcare systems and economic development efforts. In response to this pressing issue, both governmental bodies and non-governmental organizations (NGOs) #Tuberculosis(TB)remainsasignificantpublichealthchallengeinNigeria